UK’s New Care Models Must Factor In Innovation
This article was originally published in Clinica
Executive Summary
Progress being made under NHS England’s one-year old Five-Year Forward View (the Stevens plan) was addressed from almost every angle at the latest Westminster Health Forum on how the national provider will deliver care with new levels of efficiency in the future.
You may also be interested in...
UK Viewpoint: AHSNs, AAR And Accelerators – Market Access & Innovation Update
Dr Charlie Davie, managing director of UCLPartners, a London-based Academic Health Science Partnership and one of the 15 UK Academic Health Science Networks, updates Medtech Insight on key changes in NHS market access policy this summer.
The Sustainability Stakes Are Rising: ‘We Cannot Recycle Our Way Out Of This’
The journey to Net Zero, described as ‘the defining issue of our time,’ will get harder in the coming decade. Failure to keep up the pressure will result in more long-term health conditions, increasing deaths and higher costs. The UK NHS is a Net Zero exemplar globally, but without a systemic approach, its compliance efforts could stutter.
UK Life Sciences Cautiously Upbeat For Investment Year Ahead – BioWales 2024
Favorable UK biopharma investment trends have been reported by the BioIndustry Association, but can medtech and healthtech share in the positivity? A roundtable at the BioWales in London 2024 event framed the outlook for non-pharma players.